Annual Meeting’s TAPUR Study: What Does it Mean for Late-Stage Cancer Patients? - 100038

Spotlight
Video

Annual Meeting’s TAPUR Study: What Does it Mean for Late-Stage Cancer Patients?

patientpower has 2417 videos Subscribe Here

Loading........
Description: Lung cancer expert and incoming ASCO President, Dr. Bruce Johnson, explains what the TAPUR (Targeted Agent and Profiling Utilization Registry) Study is and how it could affect the future of genomic testing. Dr. Johnson says, "the purpose of the study is to provide access to targeted therapy agents for patients more broadly across our oncology community." Dr. Bruce Johnson is the Chief Clinical Research Officer at Dana-Farber Cancer Institute as well as a professor of medicine at Harvard Medical School.

Produced by Patient Power and Antidote in association with the Precision Medicine for Me Initiative.

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube | http://www.youtube.com/pati...
Like on Facebook | http://www.fb.com/patientpo...
Follow on Twitter | http://www.twitter.com/pati...
Follow on Google+ | http://www.google.com/+pati...
Shared By : patientpower
Posted on : 04/10/17
Added : 10 months ago



Recommended